Multicentric Evaluation of Enhanced Recovery After Surgery Protocol in Adolescent Idiopathic Scoliosis Surgery

NCT ID: NCT06908213

Last Updated: 2025-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

316 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2029-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adolescent idiopathic scoliosis is a deformation of the spine affecting 2 to 4% of under 18 years old population. This can have severe physical or psychological impact during adulthood. The deformation causes mechanical constraints resulting in early osteoarthritis, which results in adulthood disability.

There is also an impact on the respiratory function in most severe cases of idiopathic scoliosis. Adolescents affected by a scoliosis with an angle of 40° of more undergo a surgery called posterior fusion during adolescence to limit these impacts.

In France, more than 1000 adolescent patients undergo a surgery called posterior spinal fusion for their severe scoliosis.

This aims to straighten the spine by bone grafting all the vertebras included in the scoliosis. Two metal rods are implanted to favour osteosynthesis of the straight spine.

This intervention suffer of a bad image and worries the patients and their parents, as it needs metal implants near the spinal cord.

The worry comes from the most severe complication that may happen exceptionally following this surgery, which is a definitive paraplegia. The scar is quite large and the surgery reduces the mobility of a part of the spine. The intervention produces a quite large haemorrhage, which leads to a diminution in haemoglobin level, resulting in a fatigue during the following weeks.

On the following days, the patient will need a specific protocol of pain management including morphine-based and anti-inflammatory drugs.

This intervention will often require a 5 to 7 days hospitalization with a 1 to 2 month convalescence period at home or in rehabilitation centre.

This intervention is performed on adolescent patients without comorbidities. Moreover, the surgical approach is not profound passing between the para-vertebral muscles with no close large blood vessels or major organs. The pain is caused by correction tensions and the access to the vertebras during the surgery.

Surgical techniques have considerably evolved allowing shorter interventions and to reduce the loss of blood.

The association between morphine-based treatments and grade I analgesics enables an effective pain management.

This intervention appears to perfectly suit to an enhanced recovery after surgery procedure (ERAS).

ERAS is a set of procedure meant to enhance its tolerance and to reduce its morbidity and the hospitalization duration after surgery and the recovery duration.

ERAS is well developed in adult patients undergoing surgery, it is also well described in paediatric patient especially on adolescent scoliosis surgeries.

As the pain is well controlled during the hospitalization as well when the patient get back home, there are very few obstacles to an ERAS procedure in this indication for a patient without comorbidities.

Numerous articles report experiences of medical staff with ERAS protocols.

Generally, the set of measures includes:

* Before surgery: Providing information and therapeutic patient education, iron supplementation, physiotherapy, skin disinfection, digestive preparation against constipation
* During surgery: recuperations of blood cells to limit blood loss, use of modern tools to facilitate the positioning of pedicle screws, surgery performed by 2 surgeons
* After surgery: Pain management until stopping of analgesics by patient and maintenance of a link between the patient at home and the hospital staff after end of hospitalization The articles published about ERAS reports a favourable experience of such protocols with an efficient pain management, reduced hospitalization durations without increasing morbidity or re-hospitalizations. However, no studies have studied and proved by a robust scientific method the benefits of ERAS in adolescent scoliosis.

No studies evaluate the patients' quality of life or follow the patient for more than 6 months after surgery (limiting the assessment of long term complications e.g. infectious complications).

The link between hospital staff and the patient after his return back home is not described as well.

This research project aims to confirm with a robust scientific approach that ERAS protocols in idiopathic scoliosis in adolescents allow to reduce the duration of hospitalization compared to standard of care procedures while improving quality of life after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Scoliosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective, multicenter, RIPH2
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

No masking

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group : Improved Recovery After Surgery

Patients in this group will undergo vertebral posterior fusion surgery with the Enhanced recovery after surgery protocol.

This will include at least:

* A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
* A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
* Phone calls from a surgery unit nurse 2 times a day during 5 days
* A teleconsultation with the surgeon between D3 and D5 following surgery Patients will also have a first consultation with the anesthesist and the surgeon then the surgery will be planned.

They will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Group Type EXPERIMENTAL

Posterior vertebral fusion surgery with Enhanced Recovery After Surgery (ERAS) procedure

Intervention Type PROCEDURE

This will include at least:

* A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
* A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
* Phone calls from a surgery unit nurse 2 times a day during 5 days
* A teleconsultation with the surgeon between D3 and D5 following surgery

Control group

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Group Type EXPERIMENTAL

Posterior vertebral fusion surgery with standard of care procedure

Intervention Type PROCEDURE

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Posterior vertebral fusion surgery with Enhanced Recovery After Surgery (ERAS) procedure

This will include at least:

* A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents.
* A transition to morphine based treatments per os from intravenous morphine on the second day following surgery
* Phone calls from a surgery unit nurse 2 times a day during 5 days
* A teleconsultation with the surgeon between D3 and D5 following surgery

Intervention Type PROCEDURE

Posterior vertebral fusion surgery with standard of care procedure

Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS.

They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery.

Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescents between 11 and 17 years old
* Adolescent idiopathic scoliosis diagnosis
* Posterior vertebral fusion surgery indicated to treat the patient
* Informed consent signed by both parents / legal guardians

Exclusion Criteria

* Comorbidities that might influence the duration of hospitalization (e.g. respiratory failure, diabetes…)
* Previous spine surgery
* Patient not benefiting from an health insurance plan
* Pregnant, parturient or breastfeeding woman
* Patient benefiting of psychiatric care
* Patient subject to a legal protection measure (guardianship, curatorship)
Minimum Eligible Age

11 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU d'Amiens Site Sud

Amiens, , France

Site Status

CHU de Besançon Hopital Jean Minjoz

Besançon, , France

Site Status

Pediatric orthopedic surgery unit Hôpital femme Mère Enfant (HFME)

Bron, , France

Site Status

CHU de Grenoble Hôpital Couple Enfant

La Tronche, , France

Site Status

Centre Medico-Chirurgical de Réadaptation des Massues Croix-Rouge

Lyon, , France

Site Status

AP-HM Hôpital de la Timone

Marseille, , France

Site Status

Fondation LENVAL

Nice, , France

Site Status

CHU de Saint-Etienne Hôpital Nord

Saint-Priest-en-Jarez, , France

Site Status

CHU de Toulouse

Toulouse, , France

Site Status

Clinique Médipôle Garonne

Toulouse, , France

Site Status

Clinique St Leonard

Trélazé, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vincent CUNIN

Role: CONTACT

04 27 85 51 32 ext. +33

Meriem El JANI

Role: CONTACT

04 27 85 77 25 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Richard GOURON, MD

Role: primary

03 22 08 75 50 ext. +33

Jeremie NALLET, MD

Role: primary

03 81 21 94 01 ext. +33

Vincent CUNIN, MD

Role: primary

04 27 85 51 32 ext. +33

Aurélien COURVOISIER, MD

Role: primary

04 76 76 59 00 ext. +33

Kariman ABELIN-GENEVOIS, MD

Role: primary

04 72 38 48 58 ext. +33

Sebastien PESENTI, MD

Role: primary

04 91 38 86 56 ext. +33

Frederico SOLLA, MD

Role: primary

04 92 03 04 91 ext. +33

Elie HADDAD, MD

Role: primary

04 77 82 80 37 ext. +33

Tristan LANGLAIS, MD

Role: primary

05 34 55 85 24 ext. +33

Roxane COMPAGNON, MD

Role: primary

05 62 13 28 52 ext. +33

Audrey ANGELLIAUME, MD

Role: primary

02 41 41 73 73 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL23_0742

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Indication and Treatment of Adult Kyphoscoliosis
NCT04536909 ACTIVE_NOT_RECRUITING